Evidence map›Paper›PMID 33181410›Full record

ReviewEnvironment international2021

Exposome-based public health interventions for infectious diseases in urban settings.

Xanthi D Andrianou, Anjoeka Pronk, Karen S Galea, Rob Stierum, Miranda Loh, Flavia Riccardo, Patrizio Pezzotti, Konstantinos C Makris

Open access · goldAbstract readReview
In one paragraph

Review in Environment international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. The impact of the Social Exposome in Cardiovascular Health and Disease.Journal of precision medicine (Amsterdam, Netherlands) · 2025
    Article
  3. Review
  4. Review
  5. Global research trends on the human exposome: a bibliometric analysis (2005-2024).Environmental science and pollution research international · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Xanthi D AndrianouCyprus International Institute for Environmental and Public Health, Cyprus University of Technology, Limassol, Cyprus; Department of Infectious Diseases, Italian National Institute of Health, Rome, Italy.
Anjoeka PronkThe Netherlands Organisation for Applied Scientific Research TNO, Utrecht, the Netherlands.
Karen S GaleaInstitute of Occupational Medicine (ΙΟΜ), Edinburgh, UK.
Rob StierumThe Netherlands Organisation for Applied Scientific Research TNO, Utrecht, the Netherlands.
Miranda LohInstitute of Occupational Medicine (ΙΟΜ), Edinburgh, UK.
Flavia RiccardoDepartment of Infectious Diseases, Italian National Institute of Health, Rome, Italy.
Patrizio PezzottiDepartment of Infectious Diseases, Italian National Institute of Health, Rome, Italy.
Konstantinos C MakrisCyprus International Institute for Environmental and Public Health, Cyprus University of Technology, Limassol, Cyprus. Electronic address: konstantinos.makris@cut.ac.cy.
Cyprus University of Technology · CYInstitute of Occupational Medicine · GBNetherlands Organisation for Applied Scientific Research · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic placed public health measures against infectious diseases at the core of global health challenges, especially in cities where more than half of the global population lives. SARS-CoV-2 is an exposure agent recently added to the network of exposures that comprise the human exposome, i.e. the totality of all environmental exposures throughout one's lifetime. At the same time, the application of measures to tackle SARS-CoV-2 transmission leads to changes in the exposome components and in characteristics of urban environments that define the urban exposome, a complementary concept to the human exposome, which focuses on monitoring urban health. This work highlights the use of a comprehensive systems-based approach of the exposome for better capturing the population-wide and individual-level variability in SARS-CoV-2 spread and its associated urban and individual exposures towards improved guidance and response. Population characteristics, the built environment and spatiotemporal features of city infrastructure, as well as individual characteristics/parameters, socioeconomic status, occupation and biological susceptibility need to be simultaneously considered when deploying non-pharmacological public health measures. Integrating individual and population characteristics, as well as urban-specific parameters is the prerequisite in urban exposome studies. Applications of the exposome approach in cities/towns could facilitate assessment of health disparities and better identification of vulnerable populations, as framed by multiple environmental, urban design and planning co-exposures. Exposome-based applications in epidemics control and response include the implementation of exposomic tools that have been quite mature in non-communicable disease research, ranging from biomonitoring and surveillance to sensors and modeling. Therefore, the exposome can be a novel tool in risk assessment and management during epidemics and other major public health events. This is a unique opportunity for the research community to exploit the exposome concept and its tools in upgrading and further developing site-specific public health measures in cities.

Indexed as

Communicable DiseasesCOVID-19CitiesEnvironmental ExposureExposomeHumansPandemicsPublic HealthSARS-CoV-2Urban HealthCOVID-19ExposomeInterventionsSystems-based approach

Identifiers

PMID33181410
PMCPMC7834142
OpenAlexW3103483631

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.